-
Enzian Pharmaceutics demonstrates that its expandable fibrous dosage forms enhance the bioavailability of sparingly-soluble drugs
28 Jan 2026 22:37 GMT
… To mitigate this limitation, Enzian Pharmaceutics has invented, and developed, a … #47;D6PM90004F
About Enzian Pharmaceutics
Enzian Pharmaceutics has emerged from the … SCIENCE PHARMACEUTICAL RESEARCH
SOURCE: Enzian Pharmaceutics
Copyright Business Wire 2026.
…
-
Q&A: How is Translational Pharmaceutics reshaping the drug development journey?
15 Jan 2026 03:14 GMT
… to drug development, Translational Pharmaceutics, expedite the transition from … clinical testing.
Through Translational Pharmaceutics, our integrated drug development platform … simulation support to our Translational Pharmaceutics programs.
Oral delivery of …
-
NLS Pharmaceutics Expands CNS Pipeline With AEX-6xx Series Developed by Aexon Labs
30 Oct 2025 11:58 GMT
… , Chief Executive Officer of NLS Pharmaceutics. "The DOXA series perfectly … -continental model:
About NLS Pharmaceutics Ltd.
NLS Pharmaceutics (Nasdaq: NLSP) is a …
Investor & Media Contacts
NLS Pharmaceutics Ltd. – InvestorRelations@nls-pharma.com …
-
NLS Pharmaceutics and Kadimastem Announce Completion of Material Conditions Precedent for Merger Transaction and Delisting Date of Kadimastem's Shares
29 Oct 2025 09:35 GMT
… merger between the Company, NLS Pharmaceutics (Israel) Ltd., and Kadimastem (the … or soon thereafter.
About NLS Pharmaceutics
NLS Pharmaceutics Ltd. (NASDAQ: NLSP) is … /news-releases/nls-pharmaceutics-and-kadimastem-announce-completion-of …
-
NLS Pharmaceutics And Kadimastem Unveil Multi-Target Diabetes Approach
11 Feb 2025 12:47 GMT
NLS Pharmaceutics AG (NLSP) and Kadimastem Ltd. ( … is set to position NLS Pharmaceutics and Kadimastem as leaders in …
-
Jabil Completes Acquisition of Pharmaceutics International, Inc.
06 Feb 2025 06:08 GMT
… development and manufacturing organization (CDMO) Pharmaceutics International, Inc. (Pii), which offers … ).
References
1. Jabil. Jabil Acquires Pharmaceutics International, Inc. Press Release. Feb …
-
Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Inc. Announce Exit from Pharmaceutics International, Inc.
05 Feb 2025 21:45 GMT
… exited their equity stake in Pharmaceutics International, Inc. (“Pii”), a contract … legal counsel for Pii.
About Pharmaceutics International, Inc.
Pii is a …
-
Jabil acquires Pharmaceutics International, Inc.
05 Feb 2025 20:00 GMT
Jabil has acquired of Pharmaceutics International, Inc. (Pii), a contract …
-
Jabil Acquires Pharmaceutics International, Inc. (Pii)
04 Feb 2025 16:08 GMT
… announced the successful acquisition of Pharmaceutics International, Inc. (Pii), a contract …
-
Kadimastem Shareholders Approved the Merger with NLS Pharmaceutics
31 Jan 2025 13:11 GMT
… 47;PRNewswire/ -- NLS Pharmaceutics Ltd. ("NLS") … health challenges.
About NLS Pharmaceutics Ltd.
NLS is … these documents from NLS Pharmaceutics using the sources … with-nls-pharmaceutics-302365225.html
SOURCE NLS Pharmaceutics Ltd.; Kadimastem …
About
© 1995-2026